|
rdfs:label
|
"Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease"@en
|
|
schema:description
|
"assaig clínic"@ca
"clinical trial"@en
"clinical trial"@en-ca
"clinical trial"@en-gb
"clinical trial"@en-us
"ensaio clínico"@gl
"ensaio clínico"@pt
"ensaio clínico"@pt-br
"ensayo clínico"@es
"ensayu clínicu"@ast
"essai clinique"@fr
"klinické štúdie"@sk
"klinika studo"@eo
"klinisch onderzoek"@nl
"studio clinico"@it
"thử nghiệm lâm sàng"@vi
"клиническое исследование"@ru
"клінічне випробування"@uk
"կլինիկական փորձարկում"@hy
"تجربة سريرية"@ar
"临床试验"@zh
"临床试验"@zh-hans
"治験"@ja
"臨床試驗"@zh-hant
"임상시험"@ko
|
|
schema:dateModified
|
"2025-02-16T11:42:10+00:00"^^xsd:dateTime
|
|
schema:version
|
2312316171
|
|
wikibase:identifiers
|
1
|
|
wikibase:sitelinks
|
0
|
|
wikibase:statements
|
21
|
|
p:P1476
|
wd:statement/Q64790189-825AEA6F-9802-4930-A5E0-8C362A1AB97E
|
|
p:P17
|
wd:statement/Q64790189-9F232B86-6366-41ED-8141-A62DE711B6C0
|
|
p:P2899
|
wd:statement/Q64790189-49159B9D-40CC-4145-83BD-1B46CFA1FF9B
|
|
p:P3098
|
wd:statement/Q64790189-528764CB-CD21-42F2-9AE8-62312001530A
|
|
p:P31
|
wd:statement/Q64790189-54B1DD1A-7CF5-4D2E-9FF3-F363838A3CC1
|
|
p:P6153
|
wd:statement/Q64790189-122BABD5-60F6-49FB-89A7-3E97E46E4A9A
|
|
wd:statement/Q64790189-1EFA6AB2-B8A2-4C6D-B436-AE39E87883E2
|
|
wd:statement/Q64790189-2C98587D-87BE-4463-9816-D66559E5D0AA
|
|
wd:statement/Q64790189-32F83C48-E9ED-422F-8681-A7AF8590D04E
|
|
wd:statement/Q64790189-32F9CF71-E1FB-4223-A668-1537138484CF
|
|
wd:statement/Q64790189-59770D58-E97D-4740-8237-ECD70CDA0DE7
|
|
wd:statement/Q64790189-60FAA7DE-5BBD-490F-9B84-8441875265D5
|
|
wd:statement/Q64790189-7613790F-2372-4241-9529-4FCAB5E914AE
|
|
wd:statement/Q64790189-7AEC93BF-A18C-4523-B427-68D9E03ECF4A
|
|
wd:statement/Q64790189-8CEFCE1C-3B8D-4C00-8C29-0B9465DDA99D
|
|
wd:statement/Q64790189-BACAB61F-3004-4AFD-9127-1F7B1FF24DE2
|
|
wd:statement/Q64790189-D6930851-C8B4-4551-AB31-BBF0BB1F4D14
|
|
wd:statement/Q64790189-DC3D3C00-5D8E-4767-A8D5-153E5F083B26
|
|
wd:statement/Q64790189-E577CA6D-8E76-45D3-9307-05A5A05ADA96
|
|
wd:statement/Q64790189-ED0A4C78-0DA5-4424-B07C-28094510B90B
|
|
p:P8363
|
wd:statement/Q64790189-176A01D7-7E5B-43F9-8B1A-5E0D8247B355
|
|
wdt:P1476
|
"An Intermediate-size, Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease"@en
|
|
wdt:P17
|
United States
|
|
wdt:P2899
|
2.0^^xsd:decimal
|
|
wdt:P3098
|
"NCT02596997"
|
|
wdt:P31
|
clinical trial
|
|
wdt:P6153
|
Yeshiva University
|
|
University of Chicago
|
|
University of Nebraska–Lincoln
|
|
Fred Hutchinson Cancer Center
|
|
University of Colorado Denver
|
|
University of Texas Southwestern Medical Center
|
|
Cook Children's Medical Center
|
|
Cleveland Clinic
|
|
Stanford University
|
|
University of Florida
|
|
Children's Hospital of Orange County
|
|
Children's National Hospital
|
|
University of California, San Diego
|
|
Medical College of Wisconsin
|
|
Washington University in St. Louis
|
|
wdt:P8363
|
expanded access
|